Campos, Susana M <br/><br/>
Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemia.  [electronic resource] 

 -  Journal of the National Comprehensive Cancer Network : JNCCN  Nov 2005 
 - 807-16 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1540-1405 
<br/><br/><label>Standard No.: </label>10.6004/jnccn.2005.0049  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anemia--chemically induced<br/>Antineoplastic Agents--adverse effects<br/>Blood Transfusion<br/>Cohort Studies<br/>Epoetin Alfa<br/>Erythropoietin--therapeutic use<br/>Female<br/>Hematinics--therapeutic use<br/>Hemoglobins--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasms--drug therapy<br/>Quality of Life<br/>Recombinant Proteins<br/>Retrospective Studies<br/>Time Factors<br/>Treatment Outcome